Advanced search

Authors whose works are in public domain in at least one jurisdiction

List of works by Julie M. Fox

1-32 of 32 results

Neutralizing human antibodies prevent Zika virus replication and fetal disease in mice

scientific article published on 7 November 2016

Modified mRNA Vaccines Protect against Zika Virus Infection

scientific article published on 16 February 2017

Modified mRNA Vaccines Protect against Zika Virus Infection

scientific article published on March 2017

Broadly Neutralizing Alphavirus Antibodies Bind an Epitope on E2 and Inhibit Entry and Egress

scientific article

Chikungunya viral arthritis in the United States: a mimic of seronegative rheumatoid arthritis

scientific article

Isolation and Characterization of Broad and Ultrapotent Human Monoclonal Antibodies with Therapeutic Activity against Chikungunya Virus

scientific article published in July 2015

Potently neutralizing and protective human antibodies against SARS-CoV-2

scientific article published on 15 July 2020

Neutralizing Monoclonal Antibodies Block Chikungunya Virus Entry and Release by Targeting an Epitope Critical to Viral Pathogenesis

scientific article

Mxra8 is a receptor for multiple arthritogenic alphaviruses

scientific article published in Nature

Chikungunya viruses that escape monoclonal antibody therapy are clinically attenuated, stable, and not purified in mosquitoes

scientific article

Pathogenic Chikungunya Virus Evades B Cell Responses to Establish Persistence

scientific article published on 20 July 2016

Inhibition of indoleamine 2,3-dioxygenase enhances the T-cell response to influenza virus infection

scientific article published on 11 April 2013

Interferon Lambda Upregulates IDO1 Expression in Respiratory Epithelial Cells After Influenza Virus Infection

scientific article published on 10 March 2015

A lipid-encapsulated mRNA encoding a potently neutralizing human monoclonal antibody protects against chikungunya infection

scientific article published on 01 May 2019

Immune-Mediated Protection and Pathogenesis of Chikungunya Virus

scientific article published on December 2016

SARS-CoV-2 infection of human ACE2-transgenic mice causes severe lung inflammation and impaired function

scientific article published on 24 August 2020

Therapeutic administration of a recombinant human monoclonal antibody reduces the severity of chikungunya virus disease in rhesus macaques

scientific article

Indoleamine 2,3-dioxygenase (IDO) activity during the primary immune response to influenza infection modifies the memory T cell response to influenza challenge

scientific article published on 04 April 2014

Antigen-specific antibody Fc glycosylation enhances humoral immunity via the recruitment of complement

scientific article published on 01 August 2018

A Potently Neutralizing Antibody Protects Mice against SARS-CoV-2 Infection

scientific article published on 26 June 2020

MUTATIONS IN THE E2 GLYCOPROTEIN AND THE 3' UNTRANSLATED REGION ENHANCE CHIKUNGUNYA VIRUS VIRULENCE IN MICE.

scientific article

Optimal therapeutic activity of monoclonal antibodies against chikungunya virus requires Fc-FcγR interaction on monocytes

scientific article published on 01 February 2019

Potently neutralizing human antibodies that block SARS-CoV-2 receptor binding and protect animals

scientific article published on 22 May 2020

A Single-Dose Intranasal ChAd Vaccine Protects Upper and Lower Respiratory Tracts against SARS-CoV-2

scientific article published on 19 August 2020

Drug analog inhibition of indoleamine 2,3-dioxygenase (IDO) activity modifies pattern recognition receptor expression and proinflammatory cytokine responses early during influenza virus infection.

scientific article

Subsisting H1N1 influenza memory responses are insufficient to protect from pandemic H1N1 influenza challenge in C57BL/6 mice

scientific article

Isospora troglodytes n. sp. (Apicomplexa: Eimeriidae), a new coccidian species from wrens of Costa Rica.

scientific article

Publisher Correction: SARS-CoV-2 infection of human ACE2-transgenic mice causes severe lung inflammation and impaired function

scientific article published on 02 September 2020

Human monoclonal antibodies against Ross River virus target epitopes within the E2 protein and protect against disease

scientific article published on 04 May 2020

A cross-reactive antibody protects against Ross River virus musculoskeletal disease despite rapid neutralization escape in mice

scientific article published on 06 August 2020

Structural basis of Chikungunya virus inhibition by monoclonal antibodies

scientific article published on 21 October 2020

An Evolutionary Insertion in the Mxra8 Receptor-Binding Site Confers Resistance to Alphavirus Infection and Pathogenesis

scientific article published on 18 February 2020